About this event

  • Date and time Wed 20 Nov 2019 from 8:45am to 4:00pm
  • Location Royal Society of Medicine
  • Organised by Gastroenterology and Hepatology

The RSM liver day will explore key advances in our understanding and management of liver disease. Plus a comprehensive review across a wide range of key hepatological conditions.

The meeting will provide a unique forum for consultant hepatologists, gastroenterologists, specialist registrars and clinical nurse specialists to discuss the current challenges and approaches to the management of liver disease.

You will learn:

  • The latest therapeutic advances in chronic liver disease
  • How to optimise outcome in alcohol-related liver disease
  • The latest therapeutic strategies for viral hepatitis
  • Optimise management in acute liver failure and the criteria for transplantation
  • Review the pathogenesis and management strategy for fatty liver disease


Standard pricing available until 19 November 2019.


RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£115.00 £95.00 £95.00 £95.00 £65.00

Non - Member

Consultant / GP Trainee AHP / Nurse / Midwife Student
£165.00 £110.00 £95.00 £70.00


View the programme

Registration, tea and coffee
Welcome and introduction

Session One

Chair: Introduction

Dr Patrick Kennedy, Reader in Hepatology and Honorary Consultant Hepatologist, Queen Mary University of London

Hepatology through the crystal ball

Professor Roger Williams, Consultant Hepatologist, King’s College London

Alcoholic liver disease

Mr Paul Richardson, Consultant Hepatologist, Royal Liverpool NHS Trust

Tea and coffee break
Decompensated liver disease

Dr Alistair O’Brien, Consultant Hepatologist, University College London Hospitals NHS Foundation Trust


Dr Will Alazawi, Consultant Hepatologist, Barts Health NHS Trust


Session two

Chair: Introduction

Dr Patrick Kennedy

Radiological evaluation of the liver, liver reserve pre-surgery and the role of PVE

Dr Dominic Yu, Consultant Radiologist, Royal Free London NHS Foundation Trust

Latest management of cholestatic liver disease

Dr Yiannis Kallis, Consultant Hepatologist, Barts Health NHS Trust

Transplant referral

Dr Mark McPhail, Senior Lecturer and Consultant in Liver Critical Care in the Institute of Liver Studies, King's College London

Questions and answers
Concluding remarks
Close of meeting


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, London, W1G 0AE, United Kingdom